
Trending News Today: Janssen Submits sBLA for Guselkumab in Psoriatic Arthritis
Top news of the day across the health care landscape.
Janssen Pharmaceuticals has submitted a supplemental Biologics License Application (sBLA) to the FDA for guselkumab (Tremfya) for the treatment of adults with active psoriatic arthritis,
An independent expert panel to the FDA recommended approval of GlaxoSmithKline’s OTC nicotine oral spray developed for smoking cessation,
E-cigarette use has continued to increase among US teens,
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.